- Home
- NAUT vs WHWK Comparison
NAUT vs WHWK Comparison
Compare NAUT & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- WHWK
- Stock Information
- Founded
- NAUT 2016
- WHWK 2007
- Country
- NAUT United States
- WHWK United States
- Employees
- NAUT N/A
- WHWK N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- NAUT Industrials
- WHWK Health Care
- Exchange
- NAUT Nasdaq
- WHWK Nasdaq
- Market Cap
- NAUT 104.7M
- WHWK 90.0M
- IPO Year
- NAUT N/A
- WHWK N/A
- Fundamental
- Price
- NAUT $0.90
- WHWK $2.19
- Analyst Decision
- NAUT Strong Sell
- WHWK
- Analyst Count
- NAUT 1
- WHWK 0
- Target Price
- NAUT $1.75
- WHWK N/A
- AVG Volume (30 Days)
- NAUT 394.7K
- WHWK 133.0K
- Earning Date
- NAUT 10-28-2025
- WHWK 11-15-2025
- Dividend Yield
- NAUT N/A
- WHWK N/A
- EPS Growth
- NAUT N/A
- WHWK N/A
- EPS
- NAUT N/A
- WHWK N/A
- Revenue
- NAUT N/A
- WHWK $21,596,000.00
- Revenue This Year
- NAUT N/A
- WHWK N/A
- Revenue Next Year
- NAUT N/A
- WHWK N/A
- P/E Ratio
- NAUT N/A
- WHWK N/A
- Revenue Growth
- NAUT N/A
- WHWK N/A
- 52 Week Low
- NAUT $0.62
- WHWK $1.39
- 52 Week High
- NAUT $3.03
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- NAUT 60.66
- WHWK 76.75
- Support Level
- NAUT $0.69
- WHWK $1.85
- Resistance Level
- NAUT $0.92
- WHWK $1.97
- Average True Range (ATR)
- NAUT 0.06
- WHWK 0.10
- MACD
- NAUT 0.01
- WHWK 0.02
- Stochastic Oscillator
- NAUT 70.67
- WHWK 77.27
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.